BMI View: We maintain that the growth potential of Mynamar’s pharmaceutical market can only be achieved over the long term as it is necessary for the country to improve on its basic infrastructure, which is required for the industry. In addition, due to its small market size, we expect firms to set up bases in neighbouring Vietnam or other countries in South East Asia and distribute the products from the country to Myanmar and Cambodia in order to lower overall operation costs. Headline Expenditure Projections Pharmaceuticals: MMK236.1bn (US$270mn) in 2012 to MMK268.8bn (US$290mn) in 2013; +13.8% in local currency terms …
Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=120591.
Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/myanmar-pharmaceuticals-and-healthcare-report-q4-2013-market-report.html.
No comments:
Post a Comment